SunBio PEGylation technology and PEG products have played a crucial role in many successfully
marketed biosimilar, biopharmaceutical and medical devices products worldwide.
The healthcare products under development at SunBio are listed in the table.
Category | Product/Candidate | Status | Launch |
---|---|---|---|
Biosimilar | PEG-filgrastim Biosimilar | Marketed | 2018 EU 2018 Canada 2008 India |
PEG-EPO Biosimilar | Preclinical | - | |
PEG-uricase Biosimilar | Preclinical | - | |
Medical Device | Xerostomia Treatment (MucoPEG) |
2019.11 FDA Approved | 2021 |
Viscosupplement for Arthritic Knee (SynoGEL) |
Preclinical | - | |
Biopharmaceutical | Blood Substitute (SB1) | Preclinical | - |
Brain Stroke Treatment (SB7) | Preclinical | - | |
PEG Product | PEG Derivatives Manufacture and Sales | Marketed | 1999 |